Gray JM et al. |
Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety. |
2015 |
J. Neurosci. |
pmid:25740517
|
Walentiny DM et al. |
Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice. |
2015 |
Neuropharmacology |
pmid:25698527
|
Piyanova A et al. |
Age-related changes in the endocannabinoid system in the mouse hippocampus. |
2015 |
Mech. Ageing Dev. |
pmid:26278494
|
Urquhart P et al. |
Endocannabinoids and their oxygenation by cyclo-oxygenases, lipoxygenases and other oxygenases. |
2015 |
Biochim. Biophys. Acta |
pmid:25543004
|
Ford GK et al. |
Involvement of the endocannabinoid system in attentional modulation of nociceptive behaviour in rats. |
2015 |
Eur J Pain |
pmid:25504741
|
Rapino C et al. |
Endocannabinoids as biomarkers of human reproduction. |
2014 Jul-Aug |
Hum. Reprod. Update |
pmid:24516083
|
Thieme U et al. |
Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans. |
2014 Jan-Feb |
Drug Test Anal |
pmid:24424856
|
Battista N et al. |
Analytical approaches for the determination of phytocannabinoids and endocannabinoids in human matrices. |
2014 Jan-Feb |
Drug Test Anal |
pmid:24218186
|
Pietrzak RH et al. |
Cannabinoid type 1 receptor availability in the amygdala mediates threat processing in trauma survivors. |
2014 |
Neuropsychopharmacology |
pmid:24820537
|
Ravi J et al. |
FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway. |
2014 |
Oncotarget |
pmid:24811863
|
Hama AT et al. |
Fatty acid amide hydrolase (FAAH) inhibitors exert pharmacological effects, but lack antinociceptive efficacy in rats with neuropathic spinal cord injury pain. |
2014 |
PLoS ONE |
pmid:24788435
|
Al Kury LT et al. |
Effects of the endogenous cannabinoid anandamide on voltage-dependent sodium and calcium channels in rat ventricular myocytes. |
2014 |
Br. J. Pharmacol. |
pmid:24758718
|
Nader J et al. |
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors. |
2014 |
Neuropharmacology |
pmid:24709540
|
Kaczocha M et al. |
Inhibition of fatty acid binding proteins elevates brain anandamide levels and produces analgesia. |
2014 |
PLoS ONE |
pmid:24705380
|
Pertwee RG |
Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications. |
2014 |
Proc Nutr Soc |
pmid:24135210
|
Chianese R et al. |
Hypothalamus-pituitary axis: an obligatory target for endocannabinoids to inhibit steroidogenesis in frog testis. |
2014 |
Gen. Comp. Endocrinol. |
pmid:24566122
|
Zheng Y et al. |
Dexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system. |
2014 |
Eur. J. Pharmacol. |
pmid:24508383
|
Mahavadi S et al. |
Inhibitory signaling by CB1 receptors in smooth muscle mediated by GRK5/β-arrestin activation of ERK1/2 and Src kinase. |
2014 |
Am. J. Physiol. Gastrointest. Liver Physiol. |
pmid:24407588
|
Jackson AR et al. |
Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1. |
2014 |
J. Leukoc. Biol. |
pmid:24319288
|
Okura D et al. |
The endocannabinoid anandamide inhibits voltage-gated sodium channels Nav1.2, Nav1.6, Nav1.7, and Nav1.8 in Xenopus oocytes. |
2014 |
Anesth. Analg. |
pmid:24557103
|